• Post category:Blog
  • Post comments:0 Comments
  • Reading time:9 mins read

HAEMORED-FCM 500 Injection [Ferric Carboxymaltose (500mg/10ml)]: Uses, MOA, Benefits, and Recommended Dosage

HAEMORED-FCM 500 Injection


HAEMORED-FCM 500, a flagship product from Invision Medi Sciences, delivers optimal iron supplementation through Ferric Carboxymaltose Injection. This comprehensive guide explores the uses, benefits, recommended dosage, and unique features of HAEMORED-FCM 500, dedicated to empowering health through iron support.

Empowering Health with Ferric Carboxymaltose:

HAEMORED-FCM 500 features Ferric Carboxymaltose, a complex of iron and carbohydrate, designed for effective iron supplementation. Delve into how this injection serves as a cornerstone in addressing iron deficiency and anemia.

Indications for HAEMORED-FCM 500:

HAEMORED-FCM 500 addresses three distinct indications:

  1. Iron Deficiency Anemia (IDA): HAEMORED-FCM 500 is indicated for individuals with iron deficiency anemia, providing a rapid and efficient iron boost.
  2. Intolerant to Oral Iron Therapy: For individuals facing intolerance to traditional oral iron therapy due to gastrointestinal issues or complications, HAEMORED-FCM 500 emerges as a well-tolerated alternative.
  3. Non-Dialysis Dependent Chronic Kidney Disease (CKD): Patients with CKD not requiring dialysis often encounter challenges in managing iron levels. HAEMORED-FCM 500 provides a tailored solution, addressing iron deficiency in this specific population.

Mechanism of Action (MoA):

Ferric Carboxymaltose, the powerhouse in HAEMORED-FCM 500, works by taking a unique intravenous route. Once administered, it swiftly delivers iron directly to the bloodstream. The iron forms a stable complex, allowing for a controlled and sustained release, ensuring efficient utilization by cells. This approach minimizes gastrointestinal side effects commonly seen with traditional oral iron therapies. The convenience of intravenous administration also offers a time-efficient and patient-friendly alternative.

Comparison with Traditional Iron Therapies:

Ferric Carboxymaltose outshines traditional oral iron therapies in several aspects. Firstly, it acts faster in replenishing iron stores. Its controlled release and direct delivery make it better tolerated, reducing common stomach-related side effects. The single-dose efficacy of Ferric Carboxymaltose often matches or exceeds the effectiveness of multiple oral doses, shortening the overall treatment duration. Moreover, its intravenous nature reduces the likelihood of interference with other medications or nutrients in the digestive system. The tailored dosing options further enhance its suitability for individual patient needs, marking a significant leap forward in iron supplementation.

Benefits of HAEMORED-FCM 500:

  1. Rapid Iron Repletion: Ferric Carboxymaltose allows for the rapid and efficient repletion of depleted iron stores.
  2. Improved Tolerance: The formulation enhances patient tolerance, minimizing adverse effects often associated with traditional iron therapies.
HAEMORED-FCM 500 Injection

Recommended Dosage:

Healthcare providers determine the appropriate dosage of HAEMORED-FCM 500 based on the severity of iron deficiency and individual patient needs. Adherence to the prescribed dosage is vital for optimal iron supplementation.

Potential Side Effects:

HAEMORED-FCM 500 is generally well-tolerated, but some individuals may experience mild side effects:

  • Injection Site Reactions: Localized pain or swelling at the injection site may occur.
  • Hypersensitivity: Rare instances of hypersensitivity reactions may occur.

Essential Information:

  1. Professional Administration: HAEMORED-FCM 500 is administered by healthcare professionals, ensuring proper dosage and monitoring.
  2. Precautions: Individuals with a history of hypersensitivity to iron products should exercise caution.


HAEMORED-FCM 500, featuring Ferric Carboxymaltose Injection, reflects Invision Medi Sciences’ commitment to delivering effective solutions for iron deficiency anemia. Its rapid repletion and improved tolerance showcase the dedication to empowering health through innovative medical interventions.

Related Combinations:

Explore our comprehensive range of medical solutions at Invision Medi Sciences.

ZITANEO-50: Redefining precision in glycemic control with the efficacy of Sitagliptin Phosphate 50 mg tablets.


What makes HAEMORED-FCM 500 different from other iron supplements, and how does it address Iron Deficiency Anemia?

HAEMORED-FCM 500 stands out due to its active component, Ferric Carboxymaltose, administered intravenously. This unique delivery method allows for faster iron repletion, making it an effective solution for Iron Deficiency Anemia.

Can HAEMORED-FCM 500 be used by patients with Non-Dialysis Dependent Chronic Kidney Disease (CKD), and how does it support their iron management?

Yes, HAEMORED-FCM 500 is tailored for patients with Non-Dialysis Dependent CKD. It provides targeted iron management for this specific population, contributing to overall kidney health.

Can HAEMORED-FCM 500 be self-administered?

No, HAEMORED-FCM 500 is administered by healthcare professionals to ensure accurate dosage and monitoring.

How does Ferric Carboxymaltose differ from traditional iron therapies?

Ferric Carboxymaltose offers rapid repletion with improved patient tolerance compared to traditional iron therapies.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.